WO2023006248A3 - Composition à base de protéines de légumineuse pour activer la synthèse du fgf19 - Google Patents

Composition à base de protéines de légumineuse pour activer la synthèse du fgf19 Download PDF

Info

Publication number
WO2023006248A3
WO2023006248A3 PCT/EP2022/025353 EP2022025353W WO2023006248A3 WO 2023006248 A3 WO2023006248 A3 WO 2023006248A3 EP 2022025353 W EP2022025353 W EP 2022025353W WO 2023006248 A3 WO2023006248 A3 WO 2023006248A3
Authority
WO
WIPO (PCT)
Prior art keywords
fgf19
synthesis
activating
pulse protein
based composition
Prior art date
Application number
PCT/EP2022/025353
Other languages
English (en)
Other versions
WO2023006248A2 (fr
Inventor
Catherine Lefranc-Millot
Hubert Vidal
Clémence DEFOIS
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Priority to EP22750660.7A priority Critical patent/EP4376865A2/fr
Publication of WO2023006248A2 publication Critical patent/WO2023006248A2/fr
Publication of WO2023006248A3 publication Critical patent/WO2023006248A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/14—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from leguminous or other vegetable seeds; from press-cake or oil-bearing seeds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/346—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention consiste en une composition de protéines de légumineuse, préférentiellement de pois ou de féverole, dont le degré d'hydrolyse est inférieur à 10%, en particulier pour une utilisation thérapeutique, de préférence dans la prévention et/ ou le traitement d'une maladie susceptible d'être traitée par une activation de la synthèse du FGF19 choisie parmi la sarcopénie ou la stéatohépatite non alcoolique.
PCT/EP2022/025353 2021-07-26 2022-07-26 Methode d'activation de la synthese du fgf19 WO2023006248A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP22750660.7A EP4376865A2 (fr) 2021-07-26 2022-07-26 Composition à base de protéines de légumineuse pour activer la synthèse du fgf19

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FRFR2108059 2021-07-26
FR2108059A FR3125410A1 (fr) 2021-07-26 2021-07-26 Methode d’activation de la synthese du fgf19

Publications (2)

Publication Number Publication Date
WO2023006248A2 WO2023006248A2 (fr) 2023-02-02
WO2023006248A3 true WO2023006248A3 (fr) 2023-03-23

Family

ID=78649369

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2022/025353 WO2023006248A2 (fr) 2021-07-26 2022-07-26 Methode d'activation de la synthese du fgf19

Country Status (3)

Country Link
EP (1) EP4376865A2 (fr)
FR (1) FR3125410A1 (fr)
WO (1) WO2023006248A2 (fr)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712140B1 (fr) * 2005-03-14 2008-08-20 Larena Composition alimentaire pour prévenir le syndrome de fragilité chez les personnes agées
FR3065623A1 (fr) * 2017-04-28 2018-11-02 Roquette Freres Albumines de pois ameliorees, procede d'obtention et leurs applications
WO2019068998A1 (fr) * 2017-10-04 2019-04-11 Roquette Freres Composition de protéines de pois a qualité nutritionnelle améliorée
WO2020064821A1 (fr) * 2018-09-25 2020-04-02 Roquette Freres Composition alimentaire contenant un mélange de protéines de légumineuses et de caséine
FR3089094A1 (fr) * 2018-11-30 2020-06-05 Roquette Freres Protéine de légumineuse soluble
WO2020239619A1 (fr) * 2019-05-24 2020-12-03 Cosucra Groupe Warcoing S.A. Composition comprenant de l'inuline et une protéine
US20210121493A1 (en) * 2017-07-25 2021-04-29 Cedars-Sinai Medical Center Methods for treating liver diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844515B1 (fr) 2002-09-18 2004-11-26 Roquette Freres Procede d'extraction des composants de la farine de pois
FR2889416B1 (fr) 2005-08-05 2007-10-26 Roquette Freres Composition de proteines de pois

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712140B1 (fr) * 2005-03-14 2008-08-20 Larena Composition alimentaire pour prévenir le syndrome de fragilité chez les personnes agées
FR3065623A1 (fr) * 2017-04-28 2018-11-02 Roquette Freres Albumines de pois ameliorees, procede d'obtention et leurs applications
US20210121493A1 (en) * 2017-07-25 2021-04-29 Cedars-Sinai Medical Center Methods for treating liver diseases
WO2019068998A1 (fr) * 2017-10-04 2019-04-11 Roquette Freres Composition de protéines de pois a qualité nutritionnelle améliorée
WO2020064821A1 (fr) * 2018-09-25 2020-04-02 Roquette Freres Composition alimentaire contenant un mélange de protéines de légumineuses et de caséine
FR3089094A1 (fr) * 2018-11-30 2020-06-05 Roquette Freres Protéine de légumineuse soluble
WO2020239619A1 (fr) * 2019-05-24 2020-12-03 Cosucra Groupe Warcoing S.A. Composition comprenant de l'inuline et une protéine

Also Published As

Publication number Publication date
EP4376865A2 (fr) 2024-06-05
WO2023006248A2 (fr) 2023-02-02
FR3125410A1 (fr) 2023-01-27

Similar Documents

Publication Publication Date Title
MX2021004431A (es) Procesos novedosos.
WO2001001748A3 (fr) Composés se liant à her2
DE60219887D1 (de) N-(3,-Dimethylindolin-6-yl)ä2-ä(4-pyridylmethyl)aminoü(3-pyridyl)ücarbonsäureamid und dieses enthaltende pharmazeutische Zubereitungen.
WO2007007919A3 (fr) Nouveaux composes
WO2008050101A3 (fr) Composés chimiques
WO2000049040A3 (fr) Polypeptide antimicrobien/neutralisant des endotoxines
HK1104280A1 (en) Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
ZA202201828B (en) Therapeutic fusion proteins
WO2023006248A3 (fr) Composition à base de protéines de légumineuse pour activer la synthèse du fgf19
MX2023008923A (es) Composicion farmaceutica que comprende un derivado de difenilpirazina.
RU2008123806A (ru) Лекарственное средство, применяющееся при поражениях хряща
WO2007138382A3 (fr) Peptides cycliques destinés à moduler la croissance de néovaisseaux et leur utilisation dans l'angiogenèse thérapeutique
PT1673359E (pt) Processo para a preparação de formas cristalinas de orlistat
WO2006082581A3 (fr) Copolymeres peptidiques synthetiques pour le traitement et la prevention de troubles cardiovasculaires
WO2007125142A8 (fr) Peptides linéaires antimicrobiens
WO2008153772A3 (fr) Vaccin anti-chlamydia contenant des polypeptides htra
KR20180058926A (ko) 바실러스 아밀로리퀴파시엔스 k14로부터 단리된 신규 항균 펩타이드 및 그의 용도
WO2020198662A8 (fr) Complexes de protéines chimériques à base de clec9a
WO2001012201A8 (fr) Composition remplacant le plasma sanguin
WO2023122280A3 (fr) Compositions et procédés de traitement de défauts cutanés
WO2021245610A3 (fr) Nouvelle composition pharmaceutique comprenant une combinaison d'olopatadine et de népafénac
JOP20210197A1 (ar) طريقة تنقية مستخلص مسبب للحساسية
MX2023007029A (es) Masitinib para el tratamiento de la enfermedad de alzheimer.
WO2021111426A3 (fr) Formulation d'histatine-1 pour le traitement, la réparation ou la régénération de tissu osseux chez un sujet
GB202004879D0 (en) Peptide for use in the treatment or prevention of alzheimer's disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22750660

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2022750660

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2022750660

Country of ref document: EP

Effective date: 20240226